India – Key Facts Statement (KFS) For Loans And Advances.

- Anuroop Omkar - AK & Partners,

India – AKP Banking & Finance Digest- April 22, 2024.

- Anuroop Omkar - AK & Partners,

India – Cyril Amarchand Mangaldas Advised Aditya Birla Capital Limited On The Offer For Sale Of Equity Shares Of Aditya Birla Sun Life AMC Limited (“Company”) Through A Separate Designated Window Of The Stock Exchange.

Drug & Medical Device Litigation India 2024.

- Manisha Singh - Lex Orbis,

Stay Order Against Fact Check Unit Under Press Information Bureau Issued By Supreme Court Of India.

- Manisha Singh - Lex Orbis,

India – Regulation Of Enterprises In Core Digital Service Areas: Analysing The Draft Digital Competition Bill.

- Manisha Singh - Lex Orbis,

India – Delhi High Court Affirms Non-Extendible Trademark Evidence Deadlines.

- Manisha Singh - Lex Orbis,

India – Understanding The Infringement Of Patents By Biosimilars.

- Manisha Singh - Lex Orbis,

India – Cyril Amarchand Mangaldas Advised Apple South Asia Pte. Ltd. (Apple Group) With Respect To Its Investment In Clean Max Hyperion Power LLP (Clean Max Group).

Cyril Amarchand Mangaldas Advised Consortium Of Sumitomo Corporation, Osaka Gas Co. Ltd And Japan Overseas Infrastructure Investment Corporation For Transport & Urban Development (JOIN) (Investors) With Respect To Primary Investment In AG&P LNG Marketing Pte. Ltd Engaged In City Gas Distribution Business In India.

India – Navigating Change: Unravelling The Biological Diversity (Amendment) Act, 2023.

- Swati Sharma - Cyril Amarchand Mangaldas,

Rx For Referrals: Navigating The Ethical Considerations In India’s Medical Landscape.